Contact us

Support


Mirai Co., Ltd.

Aleksey Repik, the sole shareholder of the R-Pharm pharmaceutical company, sold 10% of his shares to the Japanese Mitsui & Co, as the Russian company’s press service told TASS. In this deal, Mitsui was given an option to expand their stake up to 20% on the same terms that the purchase of the initial 10% block. “On October 17, we closed the transaction for the acquisition of 10% in the Russian pharmaceutical company R-Pharm by the Japanese Mitsui & Co. Acquisition of a block of shares by the foreign investor was a continuation of the memorandum of cooperation signed in December 2016,” the press service stated. As Aleksey Repik, the R-Pharm’s Chairman of the Board, previously told TASS, the Japanese Mitsui Corporation will buy the initial 10% in R-Pharm for about $200 million.

17 October 2017
Vedomosti

The footprint of greenhouses in Khabarovsk Krai increased tenfold over the year, and two more greenhouse facilities will be commissioned in spring.

The greenhouse construction project is led by the Russian–Japanese company JGC Evergreen (resident of Khabarovsk Priority Development Area, with 556 million roubles in investment) and LLC Future Agricultural Technologies, which is building a greens factory in partnership with Japanese company Mirai (an investment of around $80 million).

19 February 2016
TASS
Investor
80.0 mln
Khabarovsk Krai

Investor profile

Mirai Co., Ltd.

Japan

Company's website: miraigroup.jp

T: 81 3 4334 8192

Private company

Contact: Mr. Shigeharu Shimamura, President and CEO

Japanese MIRAI CO., Ltd. is currently the leading developer of vegetable farming factories.

Subscribe to Newsletters

Email: